Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04004767 · ClinicalTrials.gov registry record
TRC-PAD Program: In-Clinic Trial-Ready Cohort
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 220
- Enrollment target
NCT04004767 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 220 participants.
The verdict
NCT04004767 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 220 participants
- Enrollment target
Study Summary
The purpose of the TRC-PAD study is to develop a large, well-characterized, biomarker-confirmed, trial-ready cohort to facilitate rapid enrollment into AD prevention trials utilizing the APT Webstudy and subsequent referral to in-clinic evaluation and biomarker confirmation. Participants with known biomarker status may have direct referral to the Trial-Ready Cohort. If you are interested in being selected for the TRC-PAD study, you should first enroll in the APT Webstudy (https://www.aptwebstudy.org/welcome).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2019-06-04 |
| Est. Completion | 2024-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04004767
The ClinicalTrials.gov registry entry for NCT04004767 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04004767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04004767 about?
NCT04004767 is a clinical study titled "TRC-PAD Program: In-Clinic Trial-Ready Cohort". The purpose of the TRC-PAD study is to develop a large, well-characterized, biomarker-confirmed, trial-ready cohort to facilitate rapid enrollment into AD prevention trials utilizing the APT Webstudy and subsequent referral to in-clinic evaluation and biomarker confirmation. Participants with known ...
What is the current status of trial NCT04004767?
This trial is currently completed. The enrollment target is 220 participants. The study started on 2019-06-04. Estimated completion is 2024-04-01.
Who is sponsoring clinical trial NCT04004767?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.